Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4

Published:1992-12 Issue:7 Volume:71 Page:1093-1102
ISSN:0092-8674
Container-title:Cell
language:en
Short-container-title:Cell

Author:

Chen Lieping,Ashe Stephanie,Brady William A.,Hellström Ingegerd,Hellström Karl Erik,Ledbetter Jeffrey A.,McGowan Patrick,Linsley Peter S.

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference52 articles.

1. CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes;Azuma;J. Exp. Med.,1992

2. Involvement of CD28 in MHC-unrestricted cytotoxicity mediated by a human natural killer leukemia cell line;Azuma;J. Immunol.,1992

3. Reversal of in vitro T cell clonal anergy by IL-2 stimulation;Beverly;Int. Immunol.,1992

4. The foreign antigen binding site and T cell recognition regions of class I histocompatability antigens;Björkman;Nature,1987

5. Toward a genetic analysis of tumor rejection antigen;Boon;Adv. Cancer Res.,1992

Cited by 1025 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phase I studies of davoceticept (ALPN-202), a PD-L1-dependent CD28 co-stimulator and dual PD-L1/CTLA-4 inhibitor, as monotherapy and in combination with pembrolizumab in advanced solid tumors (NEON-1 and NEON-2);Journal for ImmunoTherapy of Cancer;2024-08

2. CD28 co-stimulation: novel insights and applications in cancer immunotherapy;Nature Reviews Immunology;2024-07-25

3. Endolysosomal transient receptor potential mucolipins and two-pore channels: implications for cancer immunity;Frontiers in Immunology;2024-05-22

4. Pan-cancer analysis predicts CANT1 as a potential prognostic, immunologic biomarker;Cellular Signalling;2024-05

5. Regulatory T cell-mediated immunosuppression orchestrated by cancer: towards an immuno-genomic paradigm for precision medicine;Nature Reviews Clinical Oncology;2024-02-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3